article thumbnail

An unexpected mechanism regulates the immune response during parasitic infections

Medical Xpress

Researchers at the University of Lige (Belgium) have uncovered a previously unknown mechanism that regulates the immune response against parasites. This discovery could help in better-controlling inflammation and improving immune responses to infections.

article thumbnail

Moderna says its coronavirus vaccine sparks immune response in older people

Bio Pharma Dive

An initial look at the vaccine's effects on the elderly shows those in their 70s had similar responses to those under 55, Moderna told a government panel.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Moderna vaccine safe and spurs immune response in kids, company says

Bio Pharma Dive

The trial results should allow the company to ask the FDA for approval of its vaccine in younger children, just as Pfizer nears a crucial decision for its shot in 5- to 11-year olds.

article thumbnail

Study finds stem-like T cells key to lasting immune response in cancer, chronic diseases

Medical Xpress

Research, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and the Peter MacCallum Cancer Center (Peter Mac), have identified a rare type of immune cells, called stem-like T cells, that holds the key to maintaining powerful, long-term immune responses.

article thumbnail

Can Electric Fields Supercharge the Immune Response Against the Most Aggressive Brain Cancer?

Scienmag

In these patients, the augmented immune response likely stems from the presence of more tumor antigens, which, when combined with the disruptive electric fields, effectively ignite localized immune activation. The result is a more vigorous and sustained anti-tumor immune attack potentiated by pembrolizumab’s checkpoint blockade.

article thumbnail

IXCHIQ Chikungunya Vaccine Trial Shows Sustained Immune Response in Adolescents

XTalks

The study included 754 adolescents, comparing immune responses and safety profiles between vaccine and placebo groups. Chikungunya, a mosquito-borne viral disease, causes severe joint pain, fever and rash, with symptoms that can linger for months or even years.

article thumbnail

Pfizer, BioNTech to seek FDA OK for booster dose in 5- to 11-year-olds

Bio Pharma Dive

A third shot sparked a strong immune response in clinical testing, positioning the companies to make boosters available to the roughly 28 million kids in the U.S. who became eligible for their first two doses late last year.